跳至主要内容
临床试验/IRCT20220305054199N1
IRCT20220305054199N1招募中3 期

Effect of metformin on outcomes of hyperglycemia, inflammatory markers, asthma control test (ACT) and spirometry in patients with concurrent asthma and metabolic syndrome

Mazandaran University of Medical Sciences0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Patients with concurrent asthma and metabolic syndrome

排除标准

  • Patients with COPD, hypercapnic respiratory failure, bronchiectasis and respiratory system cancers
  • Patients with diabetes
  • People at high risk of malnutrition
  • Patients with renal failure with creatinine clearance less than 30 cc per minute
  • Heart Failure class 4
  • Hemoglobinopathy includes thalassemia major and intermedia and sickle cell anemia
  • severe liver failure
  • Patient with severe sepsis
  • Patient with cancer

研究者

相似试验

Effect of metformin in patients with concurrent... | 临床试验